Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
Funding by Fiscal Year
NIH fiscal year (Oct–Sep)
$156K
FY24
$50K
FY25
$398K
FY26
By Funding Mechanism
F31
1
R03
1
R33
1
Funding Gap Analysis
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for D,l-2-Hydroxyglutaric Aciduria. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Clinical ResearchTrials Active, No NIH Grants
1 clinical trial registered but no NIH-funded clinical or translational research grants found for D,L-2-hydroxyglutaric aciduria. Trials may be industry-sponsored or funded through non-NIH sources.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
6 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for D,L-2-hydroxyglutaric aciduria. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(2 grants)
These grants mention D,l-2-Hydroxyglutaric Aciduria as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(2)
OtherR01Active
Targeting Defective DNA Damage Response Pathways in IDH1/2-mutant AML
Bindra, Ranjit et al.·YALE UNIVERSITY·NEW HAVEN, CT
